23.03.2015 • News • Karl-Ludwig Kley • Manager Magazin • Merck

Oschmann Set to Become Merck KGaA's CEO

Germany's Merck KGaA will promote its deputy chief executive, Stefan Oschmann, to replace current CEO Karl-Ludwig Kley next year, Manager Magazin reported on Friday.

Oschmann, 57, would take on the new role next year after the group's annual shareholder meeting in April 2016 or in September next year at the latest, when Kley's current contract expires.

The German drugs and chemicals maker last September appointed Oschmann, the head of its pharma business at the time, as deputy chief executive from January 2015 on, sharing strategic management functions and representation of the company with Kley (63).

A Merck spokeswoman said a decision on Kley's succession has not yet been made and that this would be a matter for the family-controlled group's board of partners.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.